{"paper_id":"a9d62563-31cc-4bcb-976e-1474366df38e","body_text":"Abstract\nPurpose: To determine the outcomes and logical progression of fertility treatment in women forty years and older using their own oocytes.\nMethods: This was a retrospective study in which 401 completed treatment cycles in 152 women aged forty and older were reviewed.\nResults: Assisted reproductive technology (ART) cycles (n = 58) were reviewed, comprising both in vitro fertilization (IVF) and gamete intrafallopian transfer (GIFT). Intrauterine insemination (IUI) cycles (n = 343) were reviewed, consisting of 38 unstimulated natural cycle–IUI (NC-IUI), 194 clomiphene citrate–IUI (CC-IUI), and 111 injectable gonadotropins–IUI (INJ-IUI) cycles.\nThe live birth rate of 15.5% for ART cycles was significantly higher than the live birth rate of 3.2% seen for all IUI cycles (p = 0.0007). There were no differences among treatment groups in spontaneous abortion, preterm delivery, or ectopic pregnancy rates.\nConclusions: For women ≥40 years of age who wish to use their own eggs, ART offers the best chances for conception and delivery.\nSimilar content being viewed by others\nREFERENCES\nMenken J, Trussell J, Larsen U: Age and infertility. Science 1986;233:1389-1394. Published erratum appears in Science 1986; 234:413\nNavot D, Bergh PA, Williams MA, Garrisi GJ, Guzman I, Sandler B, Grunfeld L: Poor oocyte quality rather than implantation failure as a cause of age-related decline in female fertility [see comments]. Lancet 1991;337:1375-1377\nBatista MC, Cartledge TP, Zellmer AW, Merino MJ, Axiotis C, Bremner WJ, Nieman LK: Effects of aging on menstrual cycle hormones and endometrial maturation. Fertil Steril 1995;64:492-499\nRosenwaks Z, Davis OK, Damario MA: The role of maternal age in assisted reproduction. Hum Reprod 1995;10(Suppl 1):165-173\nHull MG, Fleming CF, Hughes AO, McDermott A: The age-related decline in female fecundity: A quantitative controlled study of implanting capacity and survival of individual embryos after in vitro fertilization. Fertil Steril 1996;65:783-790\nAgarwal SK, Buyalos RP: Clomiphene citrate with intrauterine insemination: Is it effective therapy in women above the age of 35 years? Fertil Steril 1996;65:759-763\nCorsan G, Trias A, Trout S, Kemmann E: Ovulation induction combined with intrauterine insemination in women 40 years of age and older: Is it worthwhile? [see comments]. Hum Reprod 1996;11:1109-1112\nLegro RS, Shackleford DP, Moessner JM, Gnatuk CL, Dodson WC: ART in women 40 and over. Is the cost worth it? J Reprod Med 1997;42:76-82\nRevised American Fertility Society classification of endometriosis: 1985. Fertil Steril 1985;43:351-352\nHofmann GE, Sosnowski J, Scott RT, Thie J: Efficacy of selection criteria for ovarian reserve screening using the clomiphene citrate challenge test in a tertiary fertility center population. Fertil Steril 1996;66:49-53\nCampana A, Sakkas D, Stalberg A, Bianchi PG, Comte I, Pache T, Walker D: Intrauterine insemination: Evaluation of the results according to the woman's age, sperm quality, total sperm count per insemination and life table analysis. Hum Reprod 1996;11:732-736\nBrzechffa PR, Daneshmand S, Buyalos RP: Sequential clomiphene citrate and human menopausal gonadotrophin with intrauterine insemination: The effect of patient age on clinical outcome. Hum Reprod 1998;13:2110-2114\nFaddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF: Accelerated disappearance of ovarian follicles in mid-life: Implications for forecasting menopause. Hum Reprod 1992;7:1342-1346\nAbdalla HI, Burton G, Kirkland A, Johnson MR, Leonard T, Brooks AA, Studd JW: Age, pregnancy and miscarriage: Uterine versus ovarian factors. Hum Reprod 1993;8:1512-1517\nNavot D, Drews MR, Bergh PA, Guzman I, Karstaedt A, Scott RT Jr, Garrisi GJ, Hofmann GE: Age-related decline in female fertility is not due to diminished capacity of the uterus to sustain embryo implantation [see comments]. Fertil Steril 1994;61:97-101\nDodson WC, Haney AF: Controlled ovarian hyperstimulation and intrauterine insemination for treatment of infertility [see comments]. Fertil Steril 1991;55(3):457-467\nPearlstone AC, Fournet N, Gambone JC, Pang SC, Buyalos RP: Ovulation induction in women age 40 and older: The importance of basal follicle-stimulating hormone level and chronological age. Fertil Steril 1992;58:674-679\nBrzechffa PR, Buyalos RP: Female and male partner age and menotropin requirements influence pregnancy rates with human menopausal gonadotrophin therapy in combination with intrauterine insemination. Hum Reprod 1997;12:29-33\nGuzick DS, Carson SA, Coutifaris C, Overstreet JW, Factor-Litvak P, Steinkampf MP, Hill JA, Mastroianni L, Buster JE, Nakajima ST, Vogel DL, Canfield RE: Efficacy of superovulation and intrauterine insemination in the treatment of infertility. National Cooperative Reproductive Medicine Network. N Engl J Med 1999;340:177-183\nGuzick DS, Sullivan MW, Adamson GD, Cedars MI, Falk RJ, Peterson EP, Steinkampf MP: Efficacy of treatment for unexplained infertility. Fertil Steril 1998;70:207-213\nSerhal PF, Katz M, Little V, Woronowski H: Unexplained infertility-the value of Pergonal superovulation combined with intrauterine insemination. Fertil Steril 1988;49:602-606\nNulsen JC, Walsh S, Dumez S, Metzger DA: Arandomized and longitudinal study of human menopausal gonadotropin with intrauterine insemination in the treatment of infertility. Obstet Gynecol 1993;82:780-786\nLass A, Croucher C, Duffy S, Dawson K, Margara R, Winston RM: One thousand initiated cycles of in vitro fertilization in women 40 years of age. Fertil Steril 1998;70:1030-1034\nSociety for Assisted Reproductive Technology, The American Society for Reproductive Medicine: Assisted reproductive technology in the United States: 1996 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertil Steril 1999;71:798-807\nUS Department of Health and Human Services, Centers for Disease Control and Prevention: 1998 Assisted Reproductive Technology Success Rates. Dec 2000\nScott RT, Toner JP, Muasher SJ, Oehninger S, Robinson S, Rosenwaks Z: Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril 1989;51(4):651-654\nScott RT Jr, Hofmann GE, Oehninger S, Muasher SJ: Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization. Fertil Steril 1990;54(2):297-302\nMartin JS, Nisker JA, Tummon IS, Daniel SA, Auckland JL, Feyles V: Future in vitro fertilization pregnancy potential of women with variably elevated day 3 follicle-stimulating hormone levels. Fertil Steril 1996;65(6):1238-1240\nAuthor information\nAuthors and Affiliations\nRights and permissions\nAbout this article\nCite this article\nAuyeung, A., Klein, M.E., Ratts, V.S. et al. Fertility Treatment in the Forty and Older Woman. J Assist Reprod Genet 18, 638–643 (2001). https://doi.org/10.1023/A:1013159116180\nIssue date:\nDOI: https://doi.org/10.1023/A:1013159116180","source_license":"CC0","license_restricted":false}